Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,3406 EUR | -0,58% |
|
-.--% | -45,94% |
Vakgebied
Aantal werknemers: 37
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 10-01-22 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 01-11-21 |
Alan Scrivner
LAW | General Counsel | - | 01-09-21 |
Shannon McCarthy
HRO | Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 12-07-19 |
Eric Richman
BRD | Director/Board Member | 63 | 12-07-19 |
Gerald McDougall
BRD | Director/Board Member | 57 | 11-05-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 751 590 | 3 249 699 ( 86,62 %) | 0 | 86,62 % |
Bedrijfsgegevens
NeuBase Therapeutics, Inc.
350 Technology Drive Suite 421
15219, Pittsburgh
+
http://www.neubasetherapeutics.com![Adres NeuBase Therapeutics, Inc.(O7P)](https://cdn.zonebourse.com/static/address/62120068.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-45,94% | 1,39 mln. | |
+38,36% | 52,73 mld. | |
+38,93% | 39 mld. | |
-8,63% | 38,52 mld. | |
+25,46% | 30,38 mld. | |
-11,17% | 26,39 mld. | |
+11,44% | 26,08 mld. | |
+45,09% | 14,15 mld. | |
+32,93% | 12,6 mld. | |
-5,30% | 11,51 mld. |